Hyperion Therapeutics Shares Up 4.3% Following Better-Than-Expected Earnings (HPTX)
Hyperion Therapeutics (NASDAQ:HPTX)’s share price shot up 4.3% on Friday following a stronger than expected earnings report, Analyst Ratings Network.com reports. The stock traded as high as $24.04 and last traded at $22.90, with a volume of 70,625 shares changing hands. The stock had previously closed at $21.96.
The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.84. The company had revenue of $37.10 million for the quarter, compared to the consensus estimate of $22.00 million. During the same quarter in the previous year, the company posted $1.17 earnings per share. The company’s revenue for the quarter was up 408.2% on a year-over-year basis.
The stock has a 50-day moving average of $24.48 and a 200-day moving average of $26.20. The company has a market cap of $467.7 million and a P/E ratio of 17.77.
Hyperion Therapeutics, Inc (NASDAQ:HPTX)is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.
Receive News & Ratings for Hyperion Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion Therapeutics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.